ArticleMolecular cancer2021

Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer.

Matteo Allegretti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.